ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) insider James Kihara sold 474 shares of the business’s stock in a transaction that occurred on Monday, February 26th. The shares were sold at an average price of $24.67, for a total transaction of $11,693.58. Following the completion of the transaction, the insider now owns 11,391 shares […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) COO Brendan Teehan sold 624 shares of the firm’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $24.67, for a total value of $15,394.08. Following the sale, the chief operating officer now owns 31,432 shares of the company’s […]
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) gapped down prior to trading on Wednesday following a weaker than expected earnings announcement. The stock had previously closed at $26.36, but opened at $24.64. ACADIA Pharmaceuticals shares last traded at $23.85, with a volume of 261,332 shares traded. The biopharmaceutical company reported $0.28 earnings per share […]